Loading...
Nexus AG
NXU.DE•XETRA
Healthcare
Medical - Healthcare Information Services
€71.90
€0.00(0.00%)
Nexus AG (NXU.DE) Financial Performance & Statements
Review Nexus AG’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
8.28%
↑ 8.28%
Operating Income Growth
55.14%
↑ 55.14%
Net Income Growth
28.23%
↑ 28.23%
Operating Cash Flow Growth
69.50%
↑ 69.50%
Operating Margin
14.69%
↑ 14.69%
Gross Margin
40.22%
↑ 40.22%
Net Profit Margin
11.79%
↑ 11.79%
ROE
11.58%
↑ 11.58%
ROIC
11.06%
↑ 11.06%
Nexus AG (NXU.DE) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Nexus AG stock.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $70.66M | $63.14M | $64.68M | $62.99M |
Cost of Revenue | $10.91M | $49.05M | $48.55M | $47.80M |
Gross Profit | $59.75M | $14.09M | $16.12M | $15.19M |
Gross Profit Ratio | $0.85 | $0.22 | $0.25 | $0.24 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $0.00 | $0.00 | $5.84M | $1.02M |
Operating Expenses | $48.58M | $3.39M | $4.60M | $3.30M |
Total Costs & Expenses | $59.49M | $52.44M | $56.52M | $54.59M |
Interest Income | $968000.00 | $920000.00 | $990000.00 | $918000.00 |
Interest Expense | $464000.00 | $590000.00 | $788000.00 | $595000.00 |
Depreciation & Amortization | $5.29M | $4.64M | $4.46M | $4.58M |
EBITDA | $17.76M | $16.33M | $13.48M | $13.87M |
EBITDA Ratio | $0.25 | $0.26 | $0.21 | $0.22 |
Operating Income | $11.17M | $10.70M | $8.15M | $8.40M |
Operating Income Ratio | $0.16 | $0.17 | $0.13 | $0.13 |
Other Income/Expenses (Net) | $841000.00 | $399000.00 | $86000.00 | $296000.00 |
Income Before Tax | $12.008M | $11.10M | $8.24M | $8.70M |
Income Before Tax Ratio | $0.17 | $0.18 | $0.13 | $0.14 |
Income Tax Expense | $1.11M | $3.21M | $2.55M | $2.00M |
Net Income | $10.52M | $7.90M | $5.83M | $6.57M |
Net Income Ratio | $0.15 | $0.13 | $0.09 | $0.10 |
EPS | $0.61 | $0.46 | $0.34 | $0.38 |
Diluted EPS | $0.61 | $0.46 | $0.34 | $0.38 |
Weighted Avg Shares Outstanding | $17.25M | $17.25M | $17.26M | $17.26M |
Weighted Avg Shares Outstanding (Diluted) | $17.27M | $17.25M | $17.27M | $17.27M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan